Microdestructive Capillary Electrophoresis Analysis of Ink Samples
A novel microdestructive capillary electrophoresis (CE) method for the analysis of blue pen ink strokes has been published. The analysis of pen inks can be challenging because ink compositions are usually under patent, the samples are small, and inks can degrade over time.
A novel microdestructive capillary electrophoresis (CE) method for the analysis of blue pen ink strokes has been published in the Journal of Chromatography A.1 The analysis of pen inks can be challenging because ink compositions are usually under patent, the samples are small, and inks can degrade over time.
CE has previously given promising results when applied to the analysis of questionable documents, according to coauthor Matías Calcerrada. He told The Column: “We believe that CE could be an efficient analytical technique for casework involving questioned documents, due to advantages such as its minimal sample consumption and ability to detect and quantify different analytes found in ink formulations.”
The team developed a microdestructive sample treatment method using a scalpel to scratch 0.3 mg of an ink stroke from paper, prior to analysis using CE with a DAD detector. Samples of ink from 34 blue pens from different technologies (ballpoint, rollerball, marker) with different composition (gel, water-based, oil-based) were analyzed to discriminate between different technologies and inks. Calcerrada said: “We believe that the results published demonstrate that the method could be applied in forensic casework after applying other non-destructive methodologies, which are always recommended before destroying the sample.” - B.D.
Reference
1. Matías Calcerrada, Journal of Chromatography A1400, 140–148 (2015).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
